Search Results

Genome-wide analysis of histone H3 acetylation patterns in AML identifies PRDX2 as an epigenetically silenced tumor suppressor gene.

• Authors : Agrawal-Singh S; Department of Medicine, Hematology, and Oncology, University of Muenster, Germany.; Isken F

Subjects: DNA Methylation*; Histones/Histones/Histones/*metabolism ; Peroxiredoxins/Peroxiredoxins/Peroxiredoxins/*genetics

• Source: Blood [Blood] 2012 Mar 08; Vol. 119 (10), pp. 2346-57. Date of Electronic Publication: 2011 Dec 29.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Ubiquitin-dependent degradation of CDK2 drives the therapeutic differentiation of AML by targeting PRDX2.

• Authors : Ying M; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.; Shao X

Subjects: Cyclin-Dependent Kinase 2/Cyclin-Dependent Kinase 2/Cyclin-Dependent Kinase 2/*metabolism ; Leukemia, Myeloid, Acute/Leukemia, Myeloid, Acute/Leukemia, Myeloid, Acute/*metabolism ; Peroxiredoxins/Peroxiredoxins/Peroxiredoxins/*metabolism

• Source: Blood [Blood] 2018 Jun 14; Vol. 131 (24), pp. 2698-2711. Date of Electronic Publication: 2018 May 02.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

The PRDX2 gene is transcriptionally silenced and de novo methylated in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.

• Authors : Schneider M; University of Duisburg-Essen, Essen, Germany.; Szaumkessel M

Subjects: DNA Methylation*; Histones/Histones/Histones/*metabolism ; Peroxiredoxins/Peroxiredoxins/Peroxiredoxins/*genetics

• Source: Blood [Blood] 2014 Jun 05; Vol. 123 (23), pp. 3672-4.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020

Record details

Evaluation of Peroxiredoxins (PRDX1, PRDX2 and PRDX6) Expression in Patients with Chronic Myeloid Leukemia (CML) Treated with Imatinib in First Line

• Authors : Mascarenhas, Cintia; Woldmar, Lara; Almeida, Maria Helena

• Source: Blood; November 2014, Vol. 124 Issue: 21 p5545-5545, 1p

Record details

Oxidation Of Peroxiredoxins By Thioredoxin Inactivation Is Mediated In Arsenic Trioxide-Induced Reactive Oxygen Species Formation and Its Cytotoxicity In Acute Promyelocytic Leukemia Cells

• Authors : Mun, Yeung-Chul; Ahn, Jee-Young; Yoo, Eun-Sun

• Source: Blood; November 2013, Vol. 122 Issue: 21 p3858-3858, 1p

Record details

Restoration of Peroxiredoxins and Catalase Is Closely Correlated with the Level of Philadelphia Chromosome during Imatinib Therapy in CML.

• Authors : Lee, Kyoung-Eun; Woo, Hyun-Ae; Yang, Seoug-Ha

• Source: Blood; November 2007, Vol. 110 Issue: 11 p4539-4539, 1p

Record details

Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice

• Authors : Lee, Tae-Hoon; Kim, Sun-Uk; Yu, Seong-Lan

• Source: Blood; June 2003, Vol. 101 Issue: 12 p5033-5038, 6p

Record details

17R-Resolvin D1 Improves Inflammatory Cardiomyopathy in a Mouse Model of Sickle Cell Disease

• Authors : Federti, Enrica; Mattoscio, Domenico; Recchiuti, Antonio

• Source: Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p2496-2496, 1p

Record details

Circulating Primitive Erythroblasts in the Murine Embryo Undergo Complex Proteomic and Metabolomic Changes during Terminal Maturation

• Authors : Nemkov, Travis; Kingsley, Paul D.; Dzieciatkowska, Monika

• Source: Blood; November 2021, Vol. 138 Issue: 1, Number 1 Supplement 1 p851-851, 1p

Record details

Peroxiredoxins-1 and 2 Affect Proliferation and Survival of Lymphoma Cells

• Authors : Firczuk, Malgorzata; Trzeciecka, Anna; Bajor, Malgorzata

• Source: Blood; November 2014, Vol. 124 Issue: 21 p1693-1693, 1p

Record details